Cardiol Therapeutics Inc.
CRDL
$0.94
$0.011.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.34M | 13.34M | 16.21M | 21.25M | 11.76M |
| Total Receivables | 140.60K | 205.20K | 241.20K | 251.30K | 197.40K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 709.70K | 952.60K | 1.14M | 504.90K | 836.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 9.19M | 14.50M | 17.58M | 22.01M | 12.79M |
|
|
|||||
| Total Current Assets | 9.19M | 14.50M | 17.58M | 22.01M | 12.79M |
| Net Property, Plant & Equipment | 101.20K | 119.90K | 127.00K | 135.90K | 176.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 0.00 | 0.00 |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 9.30M | 14.62M | 17.71M | 22.15M | 12.97M |
|
|
|||||
| Total Accounts Payable | 2.34M | 5.86M | 5.37M | 4.85M | 5.12M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 26.50K | 26.10K | 23.80K | 22.90K | 23.50K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 2.70K |
| Total Other Current Liabilities | -- | -- | -- | -- | 2.70K |
| Total Current Liabilities | 2.36M | 5.88M | 5.39M | 4.87M | 5.15M |
|
|
|||||
| Total Current Liabilities | 2.36M | 5.88M | 5.39M | 4.87M | 5.15M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 69.80K | 78.50K | 81.00K | 87.20K | 99.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.43M | 5.96M | 5.47M | 4.96M | 5.25M |
|
|
|||||
| Common Stock & APIC | 154.69M | 152.29M | 142.71M | 141.77M | 134.82M |
| Retained Earnings | -147.83M | -143.63M | -130.48M | -124.58M | -127.10M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 6.86M | 8.66M | 12.24M | 17.19M | 7.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.86M | 8.66M | 12.24M | 17.19M | 7.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.86M | 8.66M | 12.24M | 17.19M | 7.72M |
|
|
|||||